Positron Emission Tomography (PET)- Computed Tomography (CT) for Preoperative Staging of Colorectal Cancers

Purpose: The purpose of this study is to evaluate the usefulness of positron emission tomography (PET)- computed tomography (CT) for preoperative tumor staging in cases of colorectal cancer. Methods: Between July 2006 and September 2007, seventy-six patients with a diagnosis of colorectal cancer (43 males and 33 females; mean age: 60.4±10.13 years; range: 34∼82 years) selected prospectively were studied for staging by using Chest X-ray, abdominal CT and PET-CT. Results: The sensitivities and the specificities for N-staging were 76.9% and 35.1% for CT, 61.8% and 66.7% for PET-CT, and both procedures showed a relatively low diagnostic accuracy (CT 57.9%, PET-CT 61.8%). In the PET-CT alone, six distant metastatic lesions and four multiple primary malignancies were found. The locations of the distant metastases were the liver, the axillary node, the common iliac node, the subclavicular node, the peritoneum, and the lung. The locations of the multiple primary maligancies in extracolonic sites were 3 in the thyroid and 1 in the nasopharynx. Conclusions: For N-staging, preoperative PET-CT is no more useful than CT, but PET-CT is required before surgery to find lesions that cannot be found with conventional studies.

[1]  A. Iagaru,et al.  F-18 FDG PET/CT in the Management of Thyroid Cancer , 2007, Clinical nuclear medicine.

[2]  B. Siegel,et al.  Chemotherapy-Induced Normalization of FDG Uptake by Colorectal Liver Metastases Does Not Usually Indicate Complete Pathologic Response , 2007, Journal of Gastrointestinal Surgery.

[3]  Antonio Rodríguez-Fernández,et al.  Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  A. Loft,et al.  Contrast-enhanced FDG-PET/CT vs. spio-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation , 2007, Acta radiologica.

[5]  M. Langer,et al.  Detection of recurrent rectal cancer with CT, MRI and PET/CT , 2007, European Radiology.

[6]  A. Figer,et al.  The Role and Limitations of 18-Fluoro-2-deoxy-d-glucose Positron Emission Tomography (FDG-PET) Scan and Computerized Tomography (CT) in Restaging Patients with Hepatic Colorectal Metastases Following Neoadjuvant Chemotherapy: Comparison with Operative and Pathological Findings , 2007, Journal of Gastrointestinal Surgery.

[7]  T. Beyer,et al.  Diagnostic accuracy of colorectal cancer staging with whole-body PET/CT colonography. , 2006, JAMA.

[8]  Thomas F Hany,et al.  Integrated PET/CT: current applications and future directions. , 2006, Radiology.

[9]  W. Oyen,et al.  The impact of fluor‐18‐deoxyglucose‐positron emission tomography in the management of colorectal liver metastases , 2005, Cancer.

[10]  A. Zwinderman,et al.  Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis. , 2005, Radiology.

[11]  Bruce D Cheson,et al.  Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development , 2005, Clinical Cancer Research.

[12]  Kenneth Hess,et al.  Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases , 2004, Annals of surgery.

[13]  E. Fishman,et al.  Incremental value of CT in PET/CT of patients with colorectal carcinoma , 2004, Abdominal Imaging.

[14]  M. Makuuchi,et al.  Single and multiple resections of multiple hepatic metastases of colorectal origin. , 2004, Surgery.

[15]  R. Parks,et al.  The extent of resection influences outcome following hepatectomy for colorectal liver metastases. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[16]  김광호,et al.  대장암 환자에서 술전 병기파악시 전산화 단층촬영만으로 충분한가 , 2000 .

[17]  Ludwig G. Strauss,et al.  Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients , 1996, European Journal of Nuclear Medicine.

[18]  D. Roseman,et al.  Survival after repeat hepatic resection for recurrent colorectal hepatic metastases. , 1996, Surgery.

[19]  M. Meyer Diffusely Increased Colonic F‐18 FDG Uptake in Acute Enterocolitis , 1995, Clinical nuclear medicine.

[20]  S. Hauptmann,et al.  F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. , 1994, Radiology.

[21]  E. Rota Kops,et al.  The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  A. Cohen Preoperative evaluation of patients with primary colorectal cancer , 1992, Cancer.

[23]  R L Wahl,et al.  Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. , 1992, Radiology.

[24]  H. Goel,et al.  Recent Advances In Radiation Oncology , 1991 .

[25]  Heikki Joensuu,et al.  Florodeoxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors , 1988 .

[26]  R. Halvorsen,et al.  Preoperative and postoperative CT staging of rectosigmoid carcinoma. , 1986, AJR. American journal of roentgenology.

[27]  J DeMiguel,et al.  Cancer of the colon , 1973 .

[28]  G. van Kaick,et al.  Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score. , 1992, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[29]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .